Pharmaceutical PV DIV - FSB
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- SPE2DR25D9968
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Task orders
- 0
Award facts
- Opportunity
-
- Pharmaceutical Prime Vendor Global GEN V Presolicitation Pre-Solicitation · SPE2DX24R0001 · Posted Feb 1, 2024
- Last date to order 82% complete
- IDV ceiling
- $4,999,999.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The federal contract IDV award SPE2DR25D9968 is a single-award Indefinite Delivery Contract (IDC) valued at $4,999,999.00 and issued by the Defense Logistics Agency (DLA) to the prime contractor DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract covers a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the recurring medical supply needs of military healthcare facilities and veterans' medical centers nationwide. The contract has an ultimate completion date of December 31, 2026 and is not associated with any set-aside designations, allowing DMS Pharmaceutical Group to leverage its small business status to secure direct federal awards across multiple product categories.
The contract originated from a pre-solicitation issued by the DLA Troop Support Medical Supply Chain, which plans to establish Pharmaceutical Prime Vendor Global Program Generation V contracts to provide worldwide pharmaceutical support to various DoD customers. The solicitation, expected to be issued in March 2024, will have a 30-month base period and three 30-month option periods, with an estimated total value of $30.3 billion. The awards will be made on a regional basis, with at least three different contractors selected across the North/EUCOM, West/PACOM, South/SOUTHCOM, and Fleet line items, to ensure resiliency and access to vital pharmaceuticals during contingencies or natural disasters.
Quick answers
Who was awarded contract SPE2DR25D9968?
SPE2DR25D9968 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 13, 2025.
How much is contract SPE2DR25D9968 worth?
SPE2DR25D9968's own ceiling is $4,999,999.
Who can order from contract SPE2DR25D9968?
SPE2DR25D9968 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract SPE2DR25D9968 competed?
The extent of competition for SPE2DR25D9968 was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV